Ocrevus is a medicine commonly used to treat primary progressive MS, but it can take up to four hours to receive intravenously. A new version called “Ocrevus Zunovo” was recently approved by ...

Roche has said it plans to UK price its latest multiple sclerosis drug Ocrevus in line with its close rival from Novartis - aiming to undercut some established rivals. Approved in Europe earlier ...

The FDA has approved three such drugs for MS. Ocrelizumab (Ocrevus) treats relapsing forms of MS, including: Clinically isolated syndrome Relapsing-remitting MS Active secondary progressive MS in ...

National Multiple Sclerosis Society: “FDA Approves Kesimpta® (ofatumumab), Similar to Ocrevus®, for Relapsing MS,” “Non-approved treatments used for MS disease modification,” “Ocrevus.” ...

Sally Magnusson and her family cared for their mother for many years before her death from dementia. With a possible familial link, Sally has often wondered: Will I be next? Now a cure for ...

Multiple sclerosis (MS) is typically treated with medications that aim to calm flare-ups, manage symptoms, and slow disease progression. Infusion therapy is often used to deliver certain ...

Medications are the mainstay of treatment for multiple sclerosis (MS). Many of them are used to block the immune system's attack on the nerves and slow or prevent progression and relapses (flare-ups) ...